Navigation Links
UD-developed smart gels deliver medicine on demand
Date:1/15/2014

Researchers at the University of Delaware have developed a "smart" hydrogel that can deliver medicine on demand, in response to mechanical force.

Over the past few decades, smart hydrogels have been created that respond to pH, temperature, DNA, light and other stimuli.

"The idea of a smart hydrogel that can release medicine over time is not new," said Xinqiao Jia, UD professor of materials science and engineering and biomedical engineering. "What's new is our ability to have medicine released in response to force a major challenge for people with osteoarthritis and other 'wear and tear' injuries that compromise a person's ability to perform everyday activities."

Osteoarthritis is a chronic condition that affects nearly 27 million Americans, according to the Arthritis Foundation. It is characterized by soreness or stiffness in joints following inactivity or overuse, and pain that worsens after activity or as the day progresses.

The researchers believe the hyaluronic acid-based hydrogels developed at UD can be injected into an injury site such as a knee or hip joint and that as a patient walks or participates in therapeutic exercise, the walking motion will cause accelerated release of the drug, reducing inflammation and pain.

Testing under laboratory conditions has confirmed that as the UD-developed hydrogel is compressed, the encapsulated drugs are discharged into the surrounding environment. Preliminary cell testing confirmed the anti-inflammatory activity of the released drug molecules.

Now the team is collaborating with colleagues at Rush University in Chicago to test the hydrogels in animal models. Early results indicate that the gel is biocompatible, which Jia said is because hyaluronic acid is a naturally occurring substance in cartilage, making it more readily accepted in the body.

She also said the hydrogel could help with a variety of conditions beyond osteoarthritis, including ligament tears or other injury areas under high tension.

"I have even considered whether we can leverage this hydrogel platform to reduce inflammation in patients with vocal fold disorders," Jia said.

UD collaborators on the project include Darrin Pochan, professor of materials science and engineering; Chandran Sabanayagam, an associate scientist at the Delaware Biotechnology Institute; and Longxi Xiao and Zhixiang Tong, Jia's former students, and Yingchao Chen, a current student.

An expert in microscopy and characterization techniques, Sabanayagam's role was to understand exactly how the gels behave under mechanical force and how the drug diffuses under pressure important considerations in treatment efficacy.

The research team is now investigating whether future iterations of the hydrogel can be imbued with properties that would stimulate tissue regeneration and repair.


'/>"/>

Contact: Andrea Boyle Tippet
aboyle@udel.edu
302-831-1421
University of Delaware
Source:Eurekalert  

Related biology news :

1. Programming smart molecules
2. Keep Track of Your Children & Pets With TRAX - the New Smart GPS-Tracker
3. Bait research focused on outsmarting destructive beetle
4. Social networks make us smarter
5. Fujitsu Launches Four Smartphones and Two Tablet PCs With FPC Embedded Fingerprint Technology for the Japanese Market
6. National Robotics Initiative grant to create smarter surgical robots
7. Improved smartphone microscope brings single-virus detection to remote locations
8. Researchers use smart phone photography to diagnose eye disease
9. FPC Awarded new Smartphone DW From Existing Prominent Asian OEM Customer for Launch With Leading US Operator
10. SmartMove, Inc. receives $200,000 grant from the Colorado Office of Economic Development and International Trade
11. Frost & Sullivan: Moving the Smart Cities Idea from Concept to Reality
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UD-developed smart gels deliver medicine on demand
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
(Date:2/8/2017)... -- Report Highlights The global biosurgery market ... in 2016 at a compound annual growth rate (CAGR) ... - An overview of the global market for biosurgery. ... 2015 and 2016, and projections of compound annual growth ... on the basis of product type, source, application, and ...
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... Corporation (NASDAQ: VWR), the leading global independent provider of product ... its financial results for the fourth quarter and full year ... 4Q16 record quarterly net sales of $1.13 billion, up ... 4Q16 EMEA-APAC segment net sales increased ... net sales increased 2.5%, or down 0.9% on an organic ...
(Date:2/23/2017)... Feb. 23, 2017 /PRNewswire/ - The Fight Against Cancer ... Research (OICR) are pleased to report that Fusion Pharmaceuticals ... with Johnson & Johnson Innovation – JJDC, Inc. (JJDC) ... groups HealthCap, TPG Biotechnology Partners, and Genesys Capital, as ... ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... de novo clearance to begin marketing the SPEAC® System, the Brain Sentinel® Seizure ... at home or in healthcare facilities during periods of rest. A lightweight, non-invasive ...
Breaking Biology Technology: